Casopitant and Ondansetron for Postoperative Nausea and Vomiting Prevention in Women at High Risk for Emesis: A Phase 3 Study.

  • Home/
  • Casopitant and Ondansetron for Postoperative Nausea and Vomiting Prevention in Women at High Risk for Emesis: A Phase 3 Study.

Casopitant and Ondansetron for Postoperative Nausea and Vomiting Prevention in Women at High Risk for Emesis: A Phase 3 Study.

  • Post by:
  • February 18, 2020
  • Comments off
Categories:

Address

NEMA Research, Inc.
868 106th Ave North
Naples, FL  34108

Contact Information

Call: +1 (239) 597-3594

Social Links